Parental opinions about biomedical research in children in Tours, France

E Autret1, J P Dutertre, P Barbier

  • 1Department of Clinical Pharmacology, Hôpital Bretonneau, Tours, France.

Developmental Pharmacology and Therapeutics
|January 1, 1993
PubMed

Insights

Most parents are unaware of France's clinical trial law (Loi Huriet). While few would consent to their children participating in trials, physicians should improve direct communication to enhance parental understanding and informed decisions.

Area of Science:

  • Medical Law
  • Bioethics
  • Pediatric Clinical Trials

Background:

  • Parental awareness of laws governing clinical trials is crucial for ethical research.
  • The Loi Huriet in France specifically addresses patient rights in clinical research.

Purpose of the Study:

  • To assess parental awareness of the Loi Huriet in France.
  • To understand parental attitudes towards child participation in clinical trials.
  • To identify factors influencing parental consent decisions.

Main Methods:

  • A questionnaire-based study was conducted in a French maternity unit from February to April 1991.
  • The study targeted parents in the immediate postpartum period.
  • A response rate of 59% was achieved.

Main Results:

  • 59% of parents were informed about the Loi Huriet, primarily through media (75%) and general practitioners (12%).
  • Only 21% of parents would consent to their child's participation in a clinical trial, while 74% would refuse.
  • Reasons for acceptance included benefiting others and medical progress; refusal reasons cited side effect risks and unproven efficacy.
  • Parents with higher education were more likely to accept participation.

Conclusions:

  • Parental awareness of the Loi Huriet is limited.
  • Significant parental apprehension exists regarding child participation in clinical trials.
  • Physicians should enhance direct communication with parents about clinical trials and relevant legislation.

Related Concept Videos

Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...